 |
Life Technologies (India) Pvt Ltd. 306, Agarwal City Mall, opposite M2K Pitampura, Delhi-110034 (India) Tel # +91-11-4220-8000; 4220-8111; 4220-8222 Fax# +91-11-4220-8444, Mobile# +91-98105-21400 Email# customerservice@lifetechindia.com |
Infectious Diseases
The global health crisis has been plagued by a number of infectious diseases, the treatment and prevention of which are still being investigated. Infectious disease evaluation is a specialty of Life Technologies. Currently, numerous in vitro models are being used to evaluate a number of therapeutic medicines against viral and bacterial illnesses that have grown resistant to the standard treatments. The future of combating infectious diseases lies in bold methods of drug discovery. Using in vitro and in vivo models, we were able to evaluate the novel antimicrobials and antivirals employed as vaccines to prevent infectious illnesses.
Experiments created by our team of experts are being utilized to evaluate the effectiveness of anti-infectives. It provides the motivation to help you locate evidence in the early stages to choose the most important candidate pharmaceuticals from animal models and to allow free selection of infectious agents and parasites, enabling your study on infectious diseases. Using the most recent model production technology, we may also create models specifically for your study. In your situation, our microbiology services also offer room for other pathogenic bacterial species. We cover everything, from studies conducted in hospitals to community outreach.
Discovery Services:
We cover wide range of indicators:
Viral Indicators: COVID-19, SARS, H1N1, MERS and Ebola, Influenza, Hepatitis B and C
Bacterial Indicators: Expertise in multi drug-resistant infections as clA, cUTl, HAP/VAP, ABSSI, joint infections, osteomyelitis.
Available Assays for In-Vitro Antimicrobial and Anti-Viral Studies:
Antimicrobial In Vitro Bacterial Assays Include:
- MIC assays (minimum inhibitory concentration)
- MBC assays (minimum bactericidal concentration)
- Time-kill assays
- In Vitro pharmacokinetic and pharmacodynamics assays
- Resistance testing
- Cell-based assays (internalization and killing and biofilm assays)
- Immune modulation assays (ELISA, Luminex, and FACS)
- Metagenomics
In Vitro Anti-Viral Assays:
- COVID-19 protease inhibition assay
- TCID50 assay
- EC50 /CC50 assay
- Plaque assays
- HAI assays (hemagglutination inhibition)
- Metagenomics
Available Models
Bacteria, including Gram positives and Gram-negatives covering ESKAPE pathogens
- Fungi including Candida, Aspergilli, and others
- Viruses including Respiratory Syncytial Virus (RSV)
- Parasites, including Toxoplasmosis gondii.